Infusion of Donor Lymphocytes Depleted of CD25+ Regulatory T-cells in Patients With Relapsed Hematologic Malignancies

NCT00675831 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Hematologic Malignancies

Interventions

DEVICE: CliniMACS CD25 Reagent Device

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]